Margarita Garcia-Calvo
Department of Metabolic Disorders
Merck Research Laboratories
Rahway
NJ 07065
USA
Name/email consistency: high
- The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Garcia-Calvo, M., Lisnock, J., Bull, H.G., Hawes, B.E., Burnett, D.A., Braun, M.P., Crona, J.H., Davis, H.R., Dean, D.C., Detmers, P.A., Graziano, M.P., Hughes, M., Macintyre, D.E., Ogawa, A., O'neill, K.A., Iyer, S.P., Shevell, D.E., Smith, M.M., Tang, Y.S., Makarewicz, A.M., Ujjainwalla, F., Altmann, S.W., Chapman, K.T., Thornberry, N.A. Proc. Natl. Acad. Sci. U.S.A. (2005)









